Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 109

1.

Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy.

Turkiew E, Falconer D, Reed N, Höke A.

J Peripher Nerv Syst. 2017 May 9. doi: 10.1111/jns.12219. [Epub ahead of print]

PMID:
28485482
2.

Deficiency of adaptive immunity does not interfere with Wallerian degeneration.

Cashman CR, Hoke A.

PLoS One. 2017 May 5;12(5):e0177070. doi: 10.1371/journal.pone.0177070. eCollection 2017.

3.

An Intrinsic Epigenetic Barrier for Functional Axon Regeneration.

Weng YL, An R, Cassin J, Joseph J, Mi R, Wang C, Zhong C, Jin SG, Pfeifer GP, Bellacosa A, Dong X, Hoke A, He Z, Song H, Ming GL.

Neuron. 2017 Apr 19;94(2):337-346.e6. doi: 10.1016/j.neuron.2017.03.034.

PMID:
28426967
4.

GDE2 is essential for neuronal survival in the postnatal mammalian spinal cord.

Cave C, Park S, Rodriguez M, Nakamura M, Hoke A, Pletnikov M, Sockanathan S.

Mol Neurodegener. 2017 Jan 19;12(1):8. doi: 10.1186/s13024-017-0148-1.

5.

Evolutionary perspectives: Introduction to the special issue on Axon Regeneration Across Species.

He Z, Höke A.

Exp Neurol. 2017 Jan;287(Pt 3):299. doi: 10.1016/j.expneurol.2016.11.011. No abstract available.

PMID:
27912838
6.

The astrocytic transporter SLC7A10 (Asc-1) mediates glycinergic inhibition of spinal cord motor neurons.

Ehmsen JT, Liu Y, Wang Y, Paladugu N, Johnson AE, Rothstein JD, du Lac S, Mattson MP, Höke A.

Sci Rep. 2016 Oct 19;6:35592. doi: 10.1038/srep35592.

7.

A Spontaneous Missense Mutation in Branched Chain Keto Acid Dehydrogenase Kinase in the Rat Affects Both the Central and Peripheral Nervous Systems.

Zigler JS Jr, Hodgkinson CA, Wright M, Klise A, Sundin O, Broman KW, Hejtmancik F, Huang H, Patek B, Sergeev Y, Hose S, Brayton C, Xaiodong J, Vasquez D, Maragakis N, Mori S, Goldman D, Hoke A, Sinha D.

PLoS One. 2016 Jul 29;11(7):e0160447. doi: 10.1371/journal.pone.0160447. eCollection 2016.

8.

Evidence for dying-back axonal degeneration in age-associated skeletal muscle decline.

Chung T, Park JS, Kim S, Montes N, Walston J, Höke A.

Muscle Nerve. 2016 Jul 27. doi: 10.1002/mus.25267. [Epub ahead of print]

PMID:
27464347
9.

An attenuated immune response by Schwann cells and macrophages inhibits nerve regeneration in aged rats.

Scheib JL, Höke A.

Neurobiol Aging. 2016 Sep;45:1-9. doi: 10.1016/j.neurobiolaging.2016.05.004. Epub 2016 May 11.

PMID:
27459920
10.

Impaired regeneration in aged nerves: Clearing out the old to make way for the new.

Scheib J, Höke A.

Exp Neurol. 2016 Oct;284(Pt A):79-83. doi: 10.1016/j.expneurol.2016.07.010. Epub 2016 Jul 21. Review.

PMID:
27451012
11.

Caspase-3 dependent nitrergic neuronal apoptosis following cavernous nerve injury is mediated via RhoA and ROCK activation in major pelvic ganglion.

Hannan JL, Matsui H, Sopko NA, Liu X, Weyne E, Albersen M, Watson JW, Hoke A, Burnett AL, Bivalacqua TJ.

Sci Rep. 2016 Jul 8;6:29416. doi: 10.1038/srep29416.

12.

Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity.

Zhu J, Carozzi VA, Reed N, Mi R, Marmiroli P, Cavaletti G, Hoke A.

Sci Rep. 2016 Jun 28;6:28861. doi: 10.1038/srep28861.

13.

Therapeutic augmentation of the growth hormone axis to improve outcomes following peripheral nerve injury.

Tuffaha SH, Singh P, Budihardjo JD, Means KR, Higgins JP, Shores JT, Salvatori R, Höke A, Lee WP, Brandacher G.

Expert Opin Ther Targets. 2016 Oct;20(10):1259-65. doi: 10.1080/14728222.2016.1188079. Epub 2016 May 24.

PMID:
27192539
14.

Identification of fluocinolone acetonide to prevent paclitaxel-induced peripheral neuropathy.

Cetinkaya-Fisgin A, Joo MG, Ping X, Thakor NV, Ozturk C, Hoke A, Yang IH.

J Peripher Nerv Syst. 2016 Sep;21(3):128-33. doi: 10.1111/jns.12172.

PMID:
27117347
15.

Longitudinal Assessment of Small Fiber Neuropathy: Evidence of a Non-Length-Dependent Distal Axonopathy.

Khoshnoodi MA, Truelove S, Burakgazi A, Hoke A, Mammen AL, Polydefkis M.

JAMA Neurol. 2016 Jun 1;73(6):684-90. doi: 10.1001/jamaneurol.2016.0057.

PMID:
27065313
16.

Growth Hormone Therapy Accelerates Axonal Regeneration, Promotes Motor Reinnervation, and Reduces Muscle Atrophy following Peripheral Nerve Injury.

Tuffaha SH, Budihardjo JD, Sarhane KA, Khusheim M, Song D, Broyles JM, Salvatori R, Means KR Jr, Higgins JP, Shores JT, Cooney DS, Hoke A, Lee WP, Brandacher G.

Plast Reconstr Surg. 2016 Jun;137(6):1771-80. doi: 10.1097/PRS.0000000000002188.

PMID:
26890510
17.

Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.

Ostrow KL, Donaldson K, Blakeley J, Belzberg A, Hoke A.

PLoS One. 2015 Dec 14;10(12):e0144620. doi: 10.1371/journal.pone.0144620. eCollection 2015.

18.

Use of engineered Schwann cells in peripheral neuropathy: Hopes and hazards.

Lehmann HC, Höke A.

Brain Res. 2016 May 1;1638(Pt A):97-104. doi: 10.1016/j.brainres.2015.10.040. Epub 2015 Oct 31. Review.

PMID:
26529642
19.

Paclitaxel inhibits mRNA transport in axons.

Bobylev I, Joshi AR, Barham M, Ritter C, Neiss WF, Höke A, Lehmann HC.

Neurobiol Dis. 2015 Oct;82:321-31. doi: 10.1016/j.nbd.2015.07.006. Epub 2015 Jul 15.

PMID:
26188177
20.

An exercise regimen prevents development paclitaxel induced peripheral neuropathy in a mouse model.

Park JS, Kim S, Hoke A.

J Peripher Nerv Syst. 2015 Mar;20(1):7-14. doi: 10.1111/jns.12109.

PMID:
25858462

Supplemental Content

Loading ...
Support Center